Baker Avenue Asset Management, LP Organon & Co. Transaction History

Baker Avenue Asset Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$16.59 - $23.77 $514 - $736	-31 Reduced 27.43%	82 $1,000
Q2 2023 Aug 11, 2023	SELL	$19.27 - $24.63 $250 - $320	-13 Reduced 10.32%	113 $2,000
Q1 2023 May 15, 2023	BUY	$21.42 - $32.08 $899 - $1,347	42 Added 50.0%	126 $2,000
Q4 2022 Feb 13, 2023	BUY	$23.31 - $28.61 $1,958 - $2,403	84 New	84 $2,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Baker Avenue Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Baker Avenue Asset Management, LP with notifications on news.